Detalhe da pesquisa
1.
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG.
Eur J Immunol
; 42(7): 1893-905, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585674
2.
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice.
Eur J Immunol
; 40(5): 1375-85, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20186876
3.
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.
J Immunol
; 183(6): 3682-9, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692636
4.
Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts.
Eur J Immunol
; 39(11): 3121-33, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19839008
5.
Exhaustive expansion: A novel technique for analyzing complex data generated by higher-order polychromatic flow cytometry experiments.
J Transl Med
; 8: 106, 2010 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21034498
6.
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
Clin Cancer Res
; 15(7): 2541-51, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19318471
7.
Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
Clin Cancer Res
; 14(16): 5270-83, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18698047
8.
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
J Transl Med
; 4: 24, 2006 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16772043
9.
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.
J Clin Oncol
; 21(8): 1562-73, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12697882
10.
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Clin Cancer Res
; 10(2): 668-80, 2004 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14760090
11.
Monitoring immune responses in cancer patients receiving tumor vaccines.
Int Rev Immunol
; 22(3-4): 283-319, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12745643
12.
Monitoring cytokine profiles during immunotherapy.
Immunotherapy
; 2(6): 799-816, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21091113
13.
Signaling through OX40 enhances antitumor immunity.
Semin Oncol
; 37(5): 524-32, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21074068
14.
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.
Curr Mol Med
; 9(6): 673-82, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19689294
15.
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
J Immunother
; 31(1): 43-51, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18157011